Novavax (NASDAQ: NVAX) has been a big winner for investors since the beginning of the pandemic. In this Motley Fool Live video recorded on Oct. 13, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about the outlook for Novavax. Keith Speights: There's another question on down that says, "Do you both still hold Novavax (NASDAQ: NVAX)?" Let me first say I know, Brian, you've been a shareholder of Novavax.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting